Scientists work toward a Chlamydia vaccine

Jul 25, 2006

U.S. scientists studying how the immune system responds to genital tract infections are using a mouse model to track immunity against Chlamydia.

The Harvard Medical School researchers say their findings might hasten the development of vaccines for Chlamydia -- the most common cause of bacterial sexually transmitted disease in the United States.

"Right now Chlamydia is sensitive to treatment with antibiotics," said Michael Starnbach, associate professor of microbiology and molecular genetics. "But the problem is that many people have 'silent' infections that remain untreated,

"These undiagnosed infections, over time, lead to complications like tubal pregnancy and infertility. The goal would be to vaccinate young people to keep them from suffering from undiagnosed infection and the bad outcomes associated with it."

The study -- funded by the National Institutes of Health -- appears in the early online edition of the Proceedings of the National Academy of Sciences.

Copyright 2006 by United Press International

Explore further: 12 states now reporting severe respiratory illness that targets kids

add to favorites email to friend print save as pdf

Related Stories

The mathematics of chlamydia's spread

Feb 03, 2014

(Phys.org) —It sounds an unlikely pairing: using maths to combat the spread of a sexually transmitted disease that can lead to infertility, but a group of mathematicians has delivered a solution that enables ...

Seniors' sex lives are up -- and so are STD cases

May 17, 2011

Across the nation, and especially in communities that attract a lot of older Americans, the free-love generation is continuing to enjoy an active - if not always healthy - sex life.

Alaska ranks No. 1 for chlamydia

May 05, 2011

Alaska again ranks first in the nation for chlamydia and is second for gonorrhea, state public health officials announced Tuesday.

Recommended for you

User comments : 0